Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · July 02, 2023

Effectiveness of Nusinersen in Treating Spinal Muscular Atrophy in Poland

Healthcare (Basel, Switzerland)


Additional Info

Healthcare (Basel, Switzerland)
Real World Evidence on the Effectiveness of Nusinersen within the National Program to Treat Spinal Muscular Atrophy in Poland
Healthcare (Basel) 2023 May 22;11(10)1515, D Krupa, M Czech, E Chudzyńska, B Koń, A Kostera-Pruszczyk

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading